Earmark - Combat Casualty Care for Battlefield Wounds

Agency:		Department of Defense--Military
Bureau:		Research, Development, Test, and Evaluation
Account:		Research, development, test, and evaluation, Army (21-2040)
Certifying Official:		Deputy Comptroller Program/Budget
Contact Information:		http://WWW.DOD.GOV 703-697-5131

Combat Casualty Care for Battlefield Wounds

1 recipient will receive $2,684,000. This is a first-time earmark.

Year Enacted: 2005

Description: We propose to conjugate antimicrobial and pain relief agents to the chitosan biopolymer backbone in order to increase the functionality of field-applied dressings and bandages. It is proposed to use Resodyn Corporation`s novel ResonatAcoustics mixing technology as the basis for a highly productive cell culture vaccine production system. This fundamentally new bioreactor concept opens the way to develop new, highly productive cell culture methods for vaccine production that can increase the speed and reduce the cost of vaccine production.

Beneficiary/Recipient	Amount ($K)	Program	Type	Address
Resodyn Corporation	$2,684		For-Profit	Butte, MT

Citation

Source: Appropriations Report Language - Conference

Reference: 108-622

Location: Line 29, Page 256

Citation Excerpt: Combat Casualty Care for Battlefield Wounds

Last Modified: 16-Apr-2007